Clinical trials
Terminated Phase 1 Ovarian Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
110 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2004 | 3 |
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 3 |
| 2011 | 5 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 8 |
| 2016 | 10 |
| 2017 | 6 |
| 2018 | 5 |
| 2019 | 11 |
| 2020 | 10 |
| 2021 | 10 |
| 2022 | 8 |
| 2023 | 3 |
| 2024 | 8 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 110 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 8 |
| Novartis Pharmaceuticals | 4 |
| Seagen Inc. | 4 |
| Gynecologic Oncology Group | 3 |
| Masonic Cancer Center, University of Minnesota | 3 |
| National Cancer Institute (NCI) | 3 |
| Dana-Farber Cancer Institute | 2 |
| M.D. Anderson Cancer Center | 2 |
| Seagen, a wholly owned subsidiary of Pfizer | 2 |
| University of Alabama at Birmingham | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ovarian Neoplasms | 110 |
| Carcinoma, Non-Small-Cell Lung | 36 |
| Fallopian Tube Neoplasms | 27 |
| Breast Neoplasms | 24 |
| Melanoma | 21 |
| Colorectal Neoplasms | 19 |
| Endometrial Neoplasms | 19 |
| Carcinoma, Renal Cell | 17 |
| Stomach Neoplasms | 17 |
| Triple Negative Breast Neoplasms | 17 |
Trials
Showing 1 to 25 of 110. Each trial links to its page on Pharma Observatory.
10 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.